Decisions of the Unified Patent Court recorded under "Other" in UPC Litigation Watch, the case law database maintained by Dhenne Avocats.
UPC decisions and orders since 1 June 2023. “Decision with commentary” means the entry contains an analysis by Dhenne Avocats. “Summary available” identifies a summary; “Reference” identifies a record without a detailed case note. Open the entry for the source and, where available, the facts, reasoning and practical implications. The official decision is authoritative.
Combinable filters, search within the records or the full text of the decisions, copy reference, selection and export. The keyword and reference search above remains available.
11 decisions recorded
In an order of 28 October 2026 (UPC_CFI_1160/2026), the Munich Local Division, sitting as a full panel, rules on Edwards Lifesciences’ request to lay open books within its application for the determination of damages following the final decision of 4 April 2025…
Read the analysisIn a decision of 27 October 2026, issued in German (UPC_CFI_714/2025, UPC_CFI_3019/2026 and UPC_CFI_3020/2026, EP 4 283 140), the Munich Central Division rules on cross-applications for cost assessment following the decision of 21 July 2026 that partially revoked the patent and allocated…
Read the analysisBy order of 24 August 2026 (UPC_CFI_2665/2026 and UPC_CFI_539/2025), the judge-rapporteur of the Lisbon Local Division stayed Ericsson's applications against ASUSTek for re-establishment of rights (Rule 320 RoP) and for costs (Rule 150 RoP), pending the Court of Appeal's decision on the…
Read the analysisIn an order of 11 August 2026 under Rule 105.5 RoP following the interim conference (UPC_CFI_1160/2026), the judge-rapporteur of the Munich Local Division organises the damages proceedings brought by Edwards Lifesciences Corporation against Meril GmbH, Meril Life Sciences Pvt Ltd.
Read the analysisIn a decision of 6 August 2026 (UPC_CFI_1569/2025), the judge-rapporteur of the Munich Local Division fixes the costs recoverable by Niche Biomedical, Inc. (ANEUVO) from ONWARD Medical N.V.
Read the analysisIn a decision of 10 July 2026 (UPC_CFI_1968/2026), the judge-rapporteur of the Milan Central Division orders the Academy of Military Medical Sciences (AMMS), proprietor of EP 3 854 403, to pay Gilead Sciences EUR 800,000 in recoverable costs within four weeks of…
Read the analysisIn a decision of 9 July 2026, given in cost proceedings UPC_CFI_1849/2026 and UPC_CFI_1861/2026, the judge-rapporteur of the Hamburg Local Division orders Teleflex Life Sciences II to reimburse Speed Care Mineral EUR 211,000 (EUR 200,000 in representation costs, the applicable ceiling, and…
Read the analysisBy order of 30 June 2026, made in appeals UPC_CoA_692/2025 and UPC_CoA_854/2025 against the decision of the Hamburg Local Division of 10 July 2025 concerning EP 2 642 632, the Court of Appeal disregards a private expert opinion and a handbook extract…
Read the analysis